MedTrace Logo

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants

NCT00874068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2011-02-24

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on bone strength parameters.

Conditions

  • Personal Satisfaction

Interventions

OTHER

InFat™ based infant formula

high sn-2 palmitic acid oil based infant formula

OTHER

Standard vegetable oil based infant formula

standard vegetable oil based infant formula

Sponsors & Collaborators

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Dan Nemet, MD · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874068 on ClinicalTrials.gov